ProBiotix Capitalizes On EU Monacolins Restriction With CholBiome Extension
Executive Summary
A recent decision by the European Commission provides UK microbiome specialist ProBiotix Health with an opportunity to present its CholBiome extension as an alternative to red yeast rice as a way to “maintain normal blood cholesterol levels.”
You may also be interested in...
EU Restricts Red Yeast Rice Supplements Over Safety Concerns
Restrictions on daily doses and mandatory label warnings now apply to dietary supplements containing monacolins from red yeast rice sold in the EU following long-running safety concerns about the substance.
People On The Move: Appointments At ProBiotix, EMA, Neuraxpharm
A round-up of the latest European industry appointments: ProBiotix Health names Steen Andersen as its first permanent CEO; EMA appoints Steffen Thirstrup as chief medical officer; Neuraxpharm hires former Almirall exec Alfredo Barón to lead its Spanish business.
AESGP Annual Meeting: Sustainability Optional Now, But Not For Long, Warns Haleon
European consumer health companies today have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from retailers and consumers mounting, such requirements will soon be mandatory, Haleon’s Joe Muscat warned at the recent AESGP Annual Meeting in Paris, France. To ride the climate wave, while achieving their objectives, OTC firms need to work together, he explained.